Macrogenics (MGNX) Net Income Growth (3y) (2015 - 2026)
Macrogenics (MGNX) Net Income Growth (3y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Income Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
84.25% |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
32.96% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
30.59% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
19.97% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-46.86% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
13.80% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Macrogenics |
260.14 Mn |
193.63 Mn |
- |
0.65% |
| Date | Value |
|---|
| Mar 31, 2026 |
0.65% |
| Dec 31, 2025 |
-47.04% |
| Sep 30, 2025 |
38.80% |
| Jun 30, 2025 |
4.64% |
| Mar 31, 2025 |
13.78% |
| Dec 31, 2024 |
35.78% |
| Sep 30, 2024 |
45.22% |
| Jun 30, 2024 |
-11.39% |
| Mar 31, 2024 |
-2.28% |
| Dec 31, 2023 |
-183.33% |
| Sep 30, 2023 |
0.59% |
| Jun 30, 2023 |
1.12% |
| Mar 31, 2023 |
4.90% |
| Dec 31, 2022 |
32.19% |
| Sep 30, 2022 |
13.04% |
| Jun 30, 2022 |
7.58% |
| Mar 31, 2022 |
-11.85% |
| Dec 31, 2021 |
-11.80% |
| Sep 30, 2021 |
-14.82% |
| Jun 30, 2021 |
3.13% |
